metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Smoking impact on mortality in Spain in 2012
Journal Information
Vol. 145. Issue 12.
Pages 520-525 (December 2015)
Share
Share
Download PDF
More article options
Visits
2
Vol. 145. Issue 12.
Pages 520-525 (December 2015)
Original article
Smoking impact on mortality in Spain in 2012
Impacto del consumo de tabaco sobre la mortalidad en España en el año 2012
Visits
2
Eduardo Gutiérrez-Abejóna,
Corresponding author
egutiabe@gmail.com

Corresponding author.
, Javier Rejas-Gutiérrezb, Paloma Criado-Espegelc, Eva P. Campo-Ortegaa, María T. Breñas-Villalóna, Nieves Martín-Sobrinod
a Servicio de Prestaciones Complementarias y Concierto, Dirección General de Asistencia Sanitaria, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain
b Departamento de Farmacoeconomía e Investigación de Resultados en Salud, Pfizer, S.L.U., Alcobendas, Madrid, Spain
c Servicio de Prestación Farmacéutica Dirección General de Asistencia Sanitaria, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain
d Dirección Técnica de Farmacia, Dirección General de Asistencia Sanitaria, Gerencia Regional de Salud de Castilla y León, Valladolid, Spain
Related content
Med Clin. 2015;145:532-310.1016/j.medcle.2016.04.020
Rodrigo Córdoba García
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (4)
Table 1. Relative risk of mortality due to tobacco-related diseases in smokers and former smokers compared to nonsmokers, by sex.
Table 2. Smoking prevalence in Spain.
Table 3. Population attributable fraction of mortality and mortality attributable to smoking in Spain in 2012.
Table 4. Years of potential life lost and mean years of potential life lost attributable to smoking in Spain in 2012.
Show moreShow less
Abstract
Background and objective

Smoking is an important public health problem, and is one of the main avoidable causes of morbidity and early mortality. The aim was to estimate the mortality attributable to smoking and its impact on premature mortality in Spain in the year 2012.

Patients and methods

Descriptive, cross-sectional study, carried out on the Spanish population aged ≥18 years in 2012. The prevalence of smoking by age and sex was obtained from the National Health Survey 2011–2012, and the number of deaths by age, sex and cause was obtained from the vital statistics of the National Institute of Statistics. The proportion of deaths attributable to smoking was calculated according to sex and age group, from the etiological fraction of the population. Likewise, loss of potential years of life lost (PYLL) and the mean potential years of life lost (MPYLL) were also calculated.

Results

In 2012, smoking caused 60,456 deaths which accounted for 15.23% of all deaths. Trachea–bronchial–lung cancer in men and other cardiopathies in women mostly contributed to this mortality. The PYLL were 184,426, and the MPYLL were 3.25 years in men and 2.42 years in women.

Conclusions

In 2012, every day, 125 men and 40 women die from smoking-related conditions. The smoking prevalence has diminished in comparison with previous years and the number and percentage of deaths attributable to the smoking have increased in the last 20 years.

Keywords:
Smoking
Mortality
Attributable risk
Potential years of life lost
Resumen
Antecedentes y objetivo

El tabaquismo constituye un importante problema de salud pública, siendo una de las principales causas de morbimortalidad evitable y prematura. El objetivo del estudio es describir la mortalidad atribuible al consumo de tabaco en España en 2012, y compararla con resultados de años anteriores.

Pacientes y métodos

Estudio descriptivo, transversal, realizado en población española de más de 18 años. Las fuentes de los datos fueron la encuesta nacional de salud 2011-2012 y las estadísticas vitales del Instituto Nacional de Estadística. Se calculó la proporción de muertes atribuibles al tabaco por sexo y grupo de edad a partir de la fracción etiológica poblacional. Asimismo, se calcularon los años potenciales de vida perdidos (APVP) y la media de años potenciales de vida perdidos (MAPVP).

Resultados

La prevalencia global del tabaquismo en 2012 ha sido del 23,62%, y ha provocado 60.456 muertes. El 15,23% de las muertes ocurridas en España en 2012 son atribuibles al consumo de tabaco. El cáncer de tráquea-bronquios-pulmón en varones y otras cardiopatías en mujeres fueron las que más contribuyeron a dicha mortalidad. Los APVP fueron 184.426, y la MAPVP fue de 3,25 años en varones y de 2,42 en mujeres.

Conclusiones

En el año 2012 han muerto al día 125 varones y 40 mujeres por causas atribuibles al consumo de tabaco. La prevalencia global del tabaquismo ha disminuido con respecto a años anteriores, mientras que el número y el porcentaje de muertes atribuibles al tabaquismo han aumentado en los últimos 20 años.

Palabras clave:
Tabaco
Mortalidad
Riesgo atribuible
Años potenciales de vida perdidos

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos